ClinicalTrials.Veeva

Menu

Natural Course and Prognosis of Hospitalized Patients With Cirrhosis

K

Kangbuk Samsung Hospital

Status

Enrolling

Conditions

Liver Cirrhosis

Study type

Observational

Funder types

Other

Identifiers

NCT05185154
KBSMCLC2021

Details and patient eligibility

About

The aim of this prospective study is to evaluate the natural course and prognosis of hospitalized patients with liver cirrhosis.

Full description

The aim of this prospective study is to collect data on hospitalized patients with liver cirrhosis at four institutions in Korea (Kangbuk Samsung Hospital, Hallym University Dongtan Sacred Heart Hospital, Chosun University Hospital, and National Medical Center). If patients agree to participate in this clinical trial, the patients' data (such as age, sex, height, weight, nutrition status [RFH-NPT], history of medication, laboratory findings, endoscopic findings, and radiologic findings) will be collected in a research database. The research database will be updated, every 6 months, to include data on patients' disease outcomes and follow-up care.

Enrollment

336 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hospitalized patients with liver cirrhosis
  • Admission to the hospital because of cirrhotic complications such as uncontrolled ascites, variceal bleeding, hepatic encephalopathy, hepatorenal syndrome, spontaneous bacterial peritonitis, hepatocellular carcinoma, acute kidney injury, bacterial infection, acute liver failure, and etc.

Exclusion criteria

  • Admission to the hospital without cirrhotic complications
  • Patients who refuse the follow-up of outpatient department

Trial contacts and locations

4

Loading...

Central trial contact

Won Sohn, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems